News for Reata Pharmaceuticals Stock (RETA)

RETA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 18, 2022 in the Class Action Filed on Behalf of Reata Pharmaceuticals, Inc. Limited Shareholders

PRNewsWire • 02/01/22

Bronstein, Gewirtz & Grossman, LLC Reminds Reata Pharmaceuticals, Inc. (RETA) Investors of Class Action and Encourages Investors to Contact the Firm

Newsfile Corp • 02/01/22

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Reata Pharmaceuticals, Inc. (RETA)

PRNewsWire • 01/31/22

Reata Pharmaceuticals Initiates Rolling Submission of New Drug Application with U.S. FDA for Omaveloxolone for the Treatment of Patients with Friedreich's Ataxia

Business Wire • 01/31/22

ROSEN, A LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - RETA

PRNewsWire • 01/29/22

Thornton Law Firm Reminds Reata Pharmaceuticals, Inc. (RETA) Investors of Securities Class Action

Newsfile Corp • 01/28/22

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 18, 2022 - RETA

PRNewsWire • 01/27/22

IMPORTANT INVESTOR ALERT: Expanded Class Period - REATA PHARMACEUTICALS, INC. (NASDAQ: RETA) SHAREHOLDER CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit A

PRNewsWire • 01/26/22

RETA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Reata Pharmaceuticals, Inc.

Newsfile Corp • 01/25/22

RETA ALERT: Thornton Law Firm Alerts Reata Pharmaceuticals, Inc. Investors of Securities Class Action

Newsfile Corp • 01/24/22

ROSEN, A TOP RANKED LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses Over $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action - RETA

Newsfile Corp • 01/23/22

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 18, 2022 - (RETA)

Newsfile Corp • 01/21/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - RETA

PRNewsWire • 01/21/22

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 18, 2022 - RETA

PRNewsWire • 01/20/22

DEADLINE: Investors in Reata Pharmaceuticals, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RETA

Newsfile Corp • 01/20/22

Thornton Law Firm Alerts Reata Pharmaceuticals, Inc. (RETA) Investors of Securities Class Action Lawsuit

Newsfile Corp • 01/18/22

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RETA

Newsfile Corp • 01/15/22

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RETA

Newsfile Corp • 01/14/22

SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against Reata Pharmaceuticals, Inc. (RETA)

Business Wire • 01/13/22

Reata Pharmaceuticals SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reata Pharmaceuticals, Inc. - RETA

PRNewsWire • 01/13/22

REATA Pharmaceuticals Investor Alert: Thornton Law Firm Alerts Reta Investors of Class Action Lawsuit

Newsfile Corp • 01/12/22

Pomerantz Law Firm Announces the Filing of a Class Action Against Reata Pharmaceuticals, Inc. and Certain Officers - RETA

Newsfile Corp • 01/12/22

ROSEN, A TOP RANKED LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - RETA

PRNewsWire • 01/11/22

Investor Action Notice: The Schall Law Firm Encourages Investors in Reata Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 01/11/22

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - RETA

Newsfile Corp • 01/07/22